Renji Hospital
Clinical trials sponsored by Renji Hospital, explained in plain language.
-
New device aims to seal brain aneurysms without open surgery
Disease control Not yet recruitingThis study tests a flow diverter, a small mesh tube placed inside an artery, to treat brain aneurysms that are not balloon-like. The goal is to block blood flow into the aneurysm so it heals. About 168 adults aged 18 to 80 will take part. The main measure is whether the aneurysm …
Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 26, 2026 02:58 UTC
-
Could engineered immune cells tame autoimmune diseases?
Disease control Not yet recruitingThis early-phase study tests a new treatment called BEN301 for people with autoimmune diseases like scleroderma, rheumatoid arthritis, Sjogren's syndrome, and inflammatory muscle diseases. BEN301 uses specially engineered immune cells (CAR-Tregs) to calm the overactive immune sys…
Phase: EARLY_PHASE1 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Virus therapy takes on bladder cancer: new hope for High-Risk patients?
Disease control Not yet recruitingThis study tests a new treatment for high-risk bladder cancer that hasn't spread into the muscle. The treatment uses a modified virus (adenovirus) that is put directly into the bladder through a catheter. The goal is to see if the virus can kill cancer cells and prevent the cance…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 26, 2026 02:45 UTC
-
Heart attack patients: which Artery-Fixing strategy works best?
Disease control Not yet recruitingThis study looks at two ways to treat people who have had a mild heart attack and have several blocked heart arteries. One group gets all blockages fixed in one emergency procedure, while the other group gets the main blockage fixed first and the others later. The goal is to see …
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New hope for kidney cancer: experimental combo targets resistant tumors
Disease control Not yet recruitingThis study tests a new drug (JS004) combined with toripalimab in 31 adults with advanced kidney cancer that got worse after prior immunotherapy. The goal is to see if the combination can shrink tumors or stop them from growing. Participants receive treatment for up to 2 years, an…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
One-and-Done bladder wash after kidney surgery may stop cancer return
Prevention Not yet recruitingThis study tests whether a single dose of the targeted drug disitamab vedotin, placed directly into the bladder right after kidney removal surgery, can prevent bladder cancer recurrence in people with HER2-positive upper tract urothelial carcinoma. About 49 participants will rece…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Prevention
Last updated May 26, 2026 02:53 UTC
-
Brain zaps may shorten Post-Surgery confusion in heart patients
Symptom relief Not yet recruitingThis study tests whether a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) can reduce the time older adults spend confused after heart surgery. About 144 patients aged 50 and older who develop delirium after their operation will receive eit…
Phase: NA • Sponsor: RenJi Hospital • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC
-
Smartwatch AI could predict heart attack recovery risks
Knowledge-focused Not yet recruitingThis study looks at whether using a smartwatch and artificial intelligence (AI) can help doctors better manage patients after a heart attack. About 200 adults who recently had a heart attack and received a stent will wear a smartwatch for 3 months after leaving the hospital. The …
Phase: NA • Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC